Revenue
attach_money18,675M CNY
YoY +9.6%
WXIBFWuXi Biologics (Cayman) Inc.$ --
WuXi Biologics (Cayman) Inc.
WXIBF
$ -
-
You can review earnings summary, quarterly trends, full-year progress, and detailed income statement data.
analyticsIncome Statement Summary
FY2024 Full YearUpdated: 12/31/2024
Operating Income
bar_chart4,974M CNY
YoY +11.8%
Net Income
verified3,356M CNY
YoY -1.3%
EPS
pie_chart0.82CNY
YoY +1.2%
Quarterly Performance
Quarterly revenue and net income trend
RevenueOperating IncomeNet Income
No quarterly data available
Full-Year Progress
Net Income Progress50.1%On Track
Revenue Progress10B
Revenue Forecast21.7B
Net Income Progress2.3B
Net Income Forecast4.7B
Income Statement Details
Item
Revenue
Cost of revenue
Gross profit
Research & development
Selling & marketing
Selling, general and administrative
Other operating expenses
Operating income
Interest expense
Income before tax
Income tax expense
Net income
Unlock Long-Term Income Statement Data
Your current plan allows viewing financial data for the latest 1 year (annual only). Upgrade to the Standard Plan to view up to 3 years (including quarterly data), or the Premium Plan to access all historical data.